Boyar Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Sell
16,532
-37
-0.2% -$2.16K 0.57% 46
2025
Q4
$894K Sell
16,569
-150
-0.9% -$7.22K 0.57% 43
2025
Q3
$754K Sell
16,719
-6,446
-28% -$301K 0.48% 43
2025
Q2
$1.07M Sell
23,165
-1,828
-7% -$89.7K 0.7% 33
2025
Q1
$1.52M Sell
24,993
-5,075
-17% -$296K 1.11% 24
2024
Q4
$1.7M Buy
30,068
+1
+0% +$56 1.12% 23
2024
Q3
$1.56M Buy
30,067
+2
+0% +$94 1% 26
2024
Q2
$1.25M Sell
30,065
-351
-1% -$15.7K 0.86% 32
2024
Q1
$1.65M Buy
30,416
+1,309
+4% +$66.7K 1.08% 26
2023
Q4
$1.49M Sell
29,107
-2,108
-7% -$111K 1.12% 24
2023
Q3
$1.81M Sell
31,215
-350
-1% -$21.4K 1.42% 18
2023
Q2
$2.02M Sell
31,565
-133
-0.4% -$8.92K 1.49% 17
2023
Q1
$2.2M Buy
31,698
+371
+1% +$26.2K 1.69% 18
2022
Q4
$2.25M Sell
31,327
-399
-1% -$30.1K 1.84% 15
2022
Q3
$2.25M Sell
31,726
-49
-0.2% -$3.55K 1.86% 18
2022
Q2
$2.45M Sell
31,775
-3,126
-9% -$238K 2.02% 16
2022
Q1
$2.55M Buy
34,901
+216
+0.6% +$14.5K 1.64% 20
2021
Q4
$2.16M Sell
34,685
-100
-0.3% -$5.87K 1.3% 23
2021
Q3
$2.06M Sell
34,785
-83
-0.2% -$5.47K 1.36% 22
2021
Q2
$2.33M Buy
34,868
+1
+0% +$65 1.5% 22
2021
Q1
$2.2M Sell
34,867
-303
-0.9% -$18.9K 1.49% 22
2020
Q4
$2.18M Sell
35,170
-2,769
-7% -$170K 1.65% 20
2020
Q3
$2.29M Buy
37,939
+715
+2% +$43K 1.92% 17
2020
Q2
$2.19M Hold
37,224
2.03% 18
2020
Q1
$2.08M Sell
37,224
-499
-1% -$30.5K 2.32% 16
2019
Q4
$2.42M Sell
37,723
-707
-2% -$40.5K 1.75% 22
2019
Q3
$1.95M Sell
38,430
-700
-2% -$32.9K 1.48% 26
2019
Q2
$1.77M Sell
39,130
-303
-0.8% -$14.1K 1.31% 26
2019
Q1
$1.88M Hold
39,433
1.41% 26
2018
Q4
$2.05M Sell
39,433
-735
-2% -$39.5K 1.69% 21
2018
Q3
$2.49M Hold
40,168
1.7% 22
2018
Q2
$2.22M Hold
40,168
1.63% 23
2018
Q1
$2.54M Sell
40,168
-247
-0.6% -$15.9K 1.85% 19
2017
Q4
$2.48M Buy
40,415
+158
+0.4% +$9.88K 1.76% 21
2017
Q3
$2.57M Hold
40,257
1.92% 22
2017
Q2
$2.24M Sell
40,257
-837
-2% -$45.5K 1.65% 26
2017
Q1
$2.23M Buy
41,094
+8,584
+26% +$471K 1.64% 25
2016
Q4
$1.9M Sell
32,510
-8,695
-21% -$475K 1.9% 23
2016
Q3
$2.22M Sell
41,205
-674
-2% -$43.3K 1.75% 23
2016
Q2
$3.08M Sell
41,879
-600
-1% -$42.4K 2.44% 14
2016
Q1
$2.71M Sell
42,479
-300
-0.7% -$18.9K 2.13% 17
2015
Q4
$2.94M Sell
42,779
-100
-0.2% -$6.61K 2.34% 17
2015
Q3
$2.54M Sell
42,879
-550
-1% -$34.9K 2.16% 17
2015
Q2
$2.89M Sell
43,429
-400
-0.9% -$26.4K 2.21% 17
2015
Q1
$2.83M Sell
43,829
-7,729
-15% -$484K 2.16% 17
2014
Q4
$3.04M Sell
51,558
-1,900
-4% -$107K 2.38% 16
2014
Q3
$2.74M Sell
53,458
-1,600
-3% -$79.9K 2.11% 19
2014
Q2
$2.67M Sell
55,058
-3,500
-6% -$172K 2.12% 20
2014
Q1
$3.04M Sell
58,558
-1,401
-2% -$74.5K 2.48% 14
2013
Q4
$3.19M Buy
59,959
+1,000
+2% +$50.9K 2.65% 12
2013
Q3
$2.73M Sell
58,959
-638
-1% -$28K 2.62% 13
2013
Q2
$2.66M Buy
+59,597
New +$2.59M 2.65% 11

Other funds holding BMY

Boyar Asset Management's BMY Position: Q1 2026 in Review

Boyar Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.22% in Q1 2026, selling an estimated $2.16K and leaving 16,532 shares worth $1M. The position accounts for 0.57% of the portfolio, ranked #46.

Boyar Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.19M in Q4 2013. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Boyar Asset Management held 16,532 shares of Bristol-Myers Squibb worth $1M as of Q1 2026.
  • Boyar Asset Management sold 37 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.16K.
  • Bristol-Myers Squibb made up 0.57% of Boyar Asset Management's portfolio in Q1 2026, its #46 holding.
  • Boyar Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Boyar Asset Management's Bristol-Myers Squibb position peaked at $3.19M in Q4 2013.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Boyar Asset Management's 13F filing for Q1 2026, filed 8 May 2026.